Irlandia - angielski - HPRA (Health Products Regulatory Authority)

martindale pharmaceuticals ltd - morphine hydrochloride dihydrocodeine hydrochloride papaverine hydrochloride - solution for injection - 15.4, 1.2, milligram

Australia - angielski - Department of Health (Therapeutic Goods Administration)

stada pharmaceuticals australia pty ltd - apomorphine hydrochloride hemihydrate, quantity: 50 mg - injection, solution - excipient ingredients: sodium metabisulfite; water for injections; hydrochloric acid - movapo pfs is indicated to reduce the number and severity of "off" phases in patients with parkinson's disease severely disabled by motor fluctuations refractory to conventional therapy. initiation of therapy with apomorphine injection should be undertaken by a specialist unit in a hospital setting. conventional therapy should be continued during "on" phases.

Irlandia - angielski - HPRA (Health Products Regulatory Authority)

martindale pharmaceuticals ltd - morphine hydrochloride dihydrocodeine hydrochloride papaverine hydrochloride - solution for injection - 15.4, 1.2, milligram

Irlandia - angielski - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - alprostadil - powder and solvent for solution for injection - 20 microgram(s) - drugs used in erectile dysfunction; alprostadil

Irlandia - angielski - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - alprostadil - powder and solvent for solution for injection - 10 microgram(s) - drugs used in erectile dysfunction; alprostadil

Irlandia - angielski - HPRA (Health Products Regulatory Authority)

bracco uk limited - iopamidol - solution for injection - 340 milligram

Irlandia - angielski - HPRA (Health Products Regulatory Authority)

bracco imaging spa - iopamidol - solution for injection - 340 milligram(s) - watersoluble, nephrotropic, low osmolar x-ray contrast media; iopamidol

Australia - angielski - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - apomorphine hydrochloride hemihydrate, quantity: 5 mg/ml - injection, solution - excipient ingredients: sodium metabisulfite; sodium chloride; hydrochloric acid; water for injections - indicated to reduce the number and severity of ?off? phases in patients with parkinson?s disease severely disabled by motor fluctuations refractory to conventional therapy. initiation of therapy with apomorphine should be undertaken in a specialist unit in a hospital setting. conventional therapy should be continued during ?on? phases.

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

amersham health inc. - diatrizoate sodium (unii: v5403h8vg7) (diatrizoic acid - unii:5uvc90j1lk) - injection, solution - 500 mg in 1 ml - hypaque sodium 50 percent is indicated for excretory urography, cerebral and peripheral angiography, aortography, intraosseous venography, direct cholangiography, hysterosalpingography, splenoportography, and contrast enhancement of computed tomographic head imaging. diatrizoate salts are used in small, medium, and large dose urography (see dosage and administration—excretory urography). visualization of the urinary tract can be achieved by either direct intravenous bolus injection, intravenous drip infusion, or incidentally following intra-arterial procedures.visualization of the urinary tract is delayed in infants less than 1 month old, and in patients with urinary tract obstruction (see clinical pharmacology). injectable radiopaque contrast media may be used to refine diagnostic precision in areas of the brain which may not otherwise have been satisfactorily visualized. radiopaque diagnostic agents may be useful to investigate the presence and extent of certain malignancies such as: gliomas including malig

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

amersham health inc. - diatrizoate meglumine (unii: 3x9mr4n98u) (diatrizoic acid - unii:5uvc90j1lk) - injection, solution - 60 g in 100 ml - hypaque meglumine 60 percent is indicated for excretory urography; cerebral angiography; peripheral arteriography; venography; operative, t-tube, or percutaneous transhepatic cholangiography; splenoportography; arthrography; discography; and contrast enhancement of computed tomographic head imaging. diatrizoate salts are used in small, medium, and large dose urography (see dosage and administration-excretory urography). visualization of the urinary tract can be achieved by either direct intravenous bolus injection, intravenous drip infusion, or incidentally following intra-arterial procedures. visualization of the urinary tract is delayed in infants less than 1 month old, and in patients with urinary tract obstruction (see clinical pharmacology). injectable radiopaque contrast media may be used to refine diagnostic precision in areas of the brain which may not otherwise have been satisfactorily visualized. radiopaque diagnostic agents may be useful to investigate the presence and extent of certain malignancie